Clinical Trials
- Colorectal Cancer
S0820, Adenoma and Second Primary Prevention Trial (PACES)
- Ages18 years and older
- GenderBoth
- Colorectal Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Digestive System
Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion 2018-07 Act Fast
- Ages40 years and older
- GenderBoth
- Digestive System
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)
- Ages60 years - 84 years
- GenderBoth
- Colorectal Cancer
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
- Colorectal Cancer
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer